Nuvectis Pharma logo

Nuvectis Pharma Share Price (NASDAQ: NVCT)

$6.5

-0.03

(-0.46%)

Live

Last updated on

Check the interactive Nuvectis Pharma Stock chart to analyse performance

Nuvectis Pharma Inc Key Stats

Check Nuvectis Pharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.53
Open
$6.66
Market Capitalization
$169.3M
Today's Volume
$55.2K
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-1.16
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-150.12%

Stock Returns calculator for Nuvectis Pharma Stock including INR - Dollar returns

The Nuvectis Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nuvectis Pharma investment value today

Current value as on today

₹1,00,906

Returns

₹906

(+0.91%)

Returns from Nuvectis Pharma Stock

₹4,271 (-4.27%)

Dollar Returns*

₹5,177 (+5.18%)

Indian investors sentiment towards Nuvectis Pharma Stock

-64%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Nuvectis Pharma Stock from India on INDmoney has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Nuvectis Pharma Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    2.79%

  • Iridian Asset Management LLC

    1.56%

  • Baldwin Brothers Inc

    1.47%

  • Geode Capital Management, LLC

    0.57%

  • Millennium Management LLC

    0.51%

  • UBS Group AG

    0.47%

Analyst Recommendation on Nuvectis Pharma Stock

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Nuvectis Pharma(by analysts ranked 0 to 5 stars)

Nuvectis Pharma Share Price Target

What analysts predicted

Upside of 179.49%

Target:

$18.17

Current:

$6.50

Nuvectis Pharma share price target is $18.17, a slight Upside of 179.49% compared to current price of $6.50 as per analysts' prediction.

Nuvectis Pharma Stock Insights

  • Price Movement

    In the last 3 months, NVCT stock has moved down by -30.3%
  • NVCT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.5% return, outperforming this stock by 61.5%
  • NVCT vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.3% return, outperforming this stock by 139.6%

Nuvectis Pharma Technicals Summary

Sell

Neutral

Buy

Nuvectis Pharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Nuvectis Pharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Nuvectis Pharma Inc logo
-13.64%
-2.54%
-3.98%
-22.38%
100.62%
Regeneron Pharmaceuticals, Inc. logo
3.77%
-17.64%
-51.18%
-2.19%
-7.17%
Beone Medicines Ltd logo
-0.02%
10.33%
51.07%
81.16%
24.14%
Vertex Pharmaceuticals Incorporated logo
-16.39%
-18.24%
-20.49%
39.42%
40.54%
Alnylam Pharmaceuticals, Inc. logo
33.05%
83.22%
57.52%
115.32%
240.85%

About Nuvectis Pharma Inc

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its lead product candidate is NXP800, a novel small molecule that is in Phase 1b clinical trial for the treatment of patients with platinum-resistant ARID1a-mutated ovarian carcinoma. The company is also developing NXP900, a small molecule drug candidate, which is in Phase 1a clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Organization
Nuvectis Pharma
Employees
13
CEO
Mr. Ron Bentsur M.B.A.
Industry
Miscellaneous

Key Management of Nuvectis Pharma Inc

NameTitle
Mr. Ron Bentsur M.B.A.
Co-Founder, Chairman, CEO & President
Dr. Enrique Poradosu Ph.D.
Co-Founder, Executive VP, Chief Scientific & Business Officer
Mr. Shay Shemesh
Co-Founder, Executive VP, Chief Development & Operations Officer
Mr. Michael Carson CPA
Vice President of Finance

Important FAQs about investing in NVCT Stock from India :

What is Nuvectis Pharma share price today?

Nuvectis Pharma share price today is $6.50 as on . Nuvectis Pharma share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Nuvectis Pharma share?

Nuvectis Pharma share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Nuvectis Pharma stock price today i.e. is trending at $6.50, lower by 44.92% versus the 52 week high.

How to invest in Nuvectis Pharma Stock (NVCT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nuvectis Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nuvectis Pharma Shares that will get you 0.2308 shares as per Nuvectis Pharma share price of $6.50 per share as on August 30, 2025 at 12:38 am IST.

What is the minimum amount required to buy Nuvectis Pharma Stock (NVCT) from India?

Indian investors can start investing in Nuvectis Pharma (NVCT) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Nuvectis Pharma stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Nuvectis Pharma share’s latest price of $6.50 as on August 30, 2025 at 12:38 am IST, you will get 1.5385 shares of Nuvectis Pharma. Learn more about fractional shares .

What are the returns that Nuvectis Pharma has given to Indian investors in the last 5 years?

Nuvectis Pharma stock has given 100.62% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?